995 related articles for article (PubMed ID: 16862465)
1. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
2. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
5. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
6. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
[TBL] [Abstract][Full Text] [Related]
7. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
[TBL] [Abstract][Full Text] [Related]
8. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
Rasmussen MH; Juul A; Hilsted J
Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
[TBL] [Abstract][Full Text] [Related]
9. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
11. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.
Sneppen SB; Lange M; Pedersen LM; Kristensen L LØ; Main KM; Juul A; Skakkebaek NE; Feldt-Rasmussen U
Growth Horm IGF Res; 2001 Dec; 11(6):384-91. PubMed ID: 11914026
[TBL] [Abstract][Full Text] [Related]
12. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
[TBL] [Abstract][Full Text] [Related]
13. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience in identical twins discordant for adult-onset growth hormone deficiency.
Simpson H; Camcho-Hübner C; Sönksen P; Russell-Jones D
J Endocrinol Invest; 1999; 22(5 Suppl):61-3. PubMed ID: 10442573
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
[TBL] [Abstract][Full Text] [Related]
17. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
[TBL] [Abstract][Full Text] [Related]
18. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
19. Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients.
Resmini E; Barreca A; Ferone D; Giusti M; Sidoti M; Minuto F
Clin Endocrinol (Oxf); 2005 Sep; 63(3):294-7. PubMed ID: 16117816
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
Domené HM; Scaglia PA; Jasper HG
Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]